170 related articles for article (PubMed ID: 34143816)
1. High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa.
Mbulawa ZZA; Somdyala NI; Mabunda SA; Williamson AL
PLoS One; 2021; 16(6):e0253074. PubMed ID: 34143816
[TBL] [Abstract][Full Text] [Related]
2. High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns.
Mbulawa ZZA; van Schalkwyk C; Hu NC; Meiring TL; Barnabas S; Dabee S; Jaspan H; Kriek JM; Jaumdally SZ; Muller E; Bekker LG; Lewis DA; Dietrich J; Gray G; Passmore JS; Williamson AL
PLoS One; 2018; 13(1):e0190166. PubMed ID: 29293566
[TBL] [Abstract][Full Text] [Related]
3. High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention.
Mbulawa ZZA; Phohlo K; Garcia-Jardon M; Williamson AL; Businge CB
PLoS One; 2022; 17(3):e0264498. PubMed ID: 35263376
[TBL] [Abstract][Full Text] [Related]
4. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction.
Shilling H; Garland SM; Atchison S; Cornall AM; Brotherton JML; Bateson D; McNamee K; Kaldor JM; Hocking JS; Chen MY; Fairley CK; McNulty A; Bell C; Marshall L; Ooi C; Skinner SR; Murray G; Molano M; Tabrizi S; Machalek DA
Vaccine; 2021 Aug; 39(34):4856-4863. PubMed ID: 34281743
[TBL] [Abstract][Full Text] [Related]
6. Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain.
Purriños-Hermida MJ; Santiago-Pérez MI; Treviño M; Dopazo R; Cañizares A; Bonacho I; Trigo M; Fernández ME; Cid A; Gómez D; Ordóñez P; Coira A; Armada MJ; Porto M; Perez S; Malvar-Pintos A;
PLoS One; 2018; 13(8):e0201653. PubMed ID: 30075010
[TBL] [Abstract][Full Text] [Related]
7. Effect of Human Papillomavirus (HPV) Education Intervention on HPV Knowledge and Awareness Among High School Learners in Eastern Cape Province of South Africa.
Mbulawa ZZA; Somdyala NI; Mabunda SA; Williamson AL
J Cancer Educ; 2023 Feb; 38(1):146-152. PubMed ID: 34581972
[TBL] [Abstract][Full Text] [Related]
8. Risk of Oral Human Papillomavirus Infection Among Sexually Active Female Adolescents Receiving the Quadrivalent Vaccine.
Schlecht NF; Masika M; Diaz A; Nucci-Sack A; Salandy A; Pickering S; Strickler HD; Shankar V; Burk RD
JAMA Netw Open; 2019 Oct; 2(10):e1914031. PubMed ID: 31651968
[TBL] [Abstract][Full Text] [Related]
9. Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening.
Shilling H; Murray G; Brotherton JML; Hawkes D; Saville M; Sivertsen T; Chambers I; Roberts J; Farnsworth A; Garland SM; Hocking JS; Kaldor J; Guy R; Atchison S; Costa AM; Molano M; Machalek DA
Vaccine; 2020 Jan; 38(5):1186-1193. PubMed ID: 31767467
[TBL] [Abstract][Full Text] [Related]
10. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
Ährlund-Richter A; Cheng L; Hu YOO; Svensson M; Pennhag AAL; Ursu RG; Haeggblom L; Grün N; Ramqvist T; Engstrand L; Dalianis T; Du J
Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454
[No Abstract] [Full Text] [Related]
11. Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda.
Franceschi S; Chantal Umulisa M; Tshomo U; Gheit T; Baussano I; Tenet V; Tshokey T; Gatera M; Ngabo F; Van Damme P; Snijders PJ; Tommasino M; Vorsters A; Clifford GM
Int J Cancer; 2016 Aug; 139(3):518-26. PubMed ID: 26991686
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.
Moodley JR; Constant D; Hoffman M; Salimo A; Allan B; Rybicki E; Hitzeroth I; Williamson AL
BMC Cancer; 2009 Aug; 9():275. PubMed ID: 19664216
[TBL] [Abstract][Full Text] [Related]
13. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.
Carozzi F; De Marco L; Gillio-Tos A; Del Mistro A; Girlando S; Baboci L; Trevisan M; Burroni E; Grasso S; Giorgi Rossi P; Ronco G;
J Clin Virol; 2014 Jul; 60(3):257-63. PubMed ID: 24815381
[TBL] [Abstract][Full Text] [Related]
14. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
[TBL] [Abstract][Full Text] [Related]
15. An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
Enerly E; Flingtorp R; Christiansen IK; Campbell S; Hansen M; Myklebust TÅ; Weiderpass E; Nygård M
PLoS One; 2019; 14(10):e0223612. PubMed ID: 31600341
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F
Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007
[TBL] [Abstract][Full Text] [Related]
17. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
18. A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls.
Draper E; Bissett SL; Howell-Jones R; Waight P; Soldan K; Jit M; Andrews N; Miller E; Beddows S
PLoS One; 2013; 8(5):e61825. PubMed ID: 23650505
[TBL] [Abstract][Full Text] [Related]
19. Misinformation Drives Low Human Papillomavirus Vaccination Coverage in South African Girls Attending Private Schools.
Milondzo T; Meyer JC; Dochez C; Burnett RJ
Front Public Health; 2021; 9():598625. PubMed ID: 33681125
[No Abstract] [Full Text] [Related]
20. Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural Eastern Cape, South Africa.
Taku O; Businge CB; Mdaka ML; Phohlo K; Basera W; Garcia-Jardon M; Meiring TL; Gyllensten U; Williamson AL; Mbulawa ZZA
Int J Infect Dis; 2020 Jun; 95():176-182. PubMed ID: 32114194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
